\-\ Texto\\:\\ \ \(0\)\
\-\ gen\\:\\ well\\ appearing\\ female\\ in\\ nad\ \(0\)\
\-\ cv\\:\\ rrr\\,\\ iii\\/vi\\ systolic\\ blowing\\ murmur\\ best\\ heard\\ at\\ the\\ rusb\\,\\ no\\ radiation\\ to\\ the\\ carotids\\,\\ no\\ jvd\ \(0\)\
\-\ pulm\\:\\ ctab\\ no\\ w\\/r\\/r\ \(0\)\
\-\ abd\\:\\ nabs\\,\\ nt\\/nd\ \(0\)\
\-\ back\\:\\ no\\ ttp\\,\\ negative\\ straight\\ leg\\ raise\\,\\ negative\\ faber\\ bilaterally\ \(0\)\
\-\ ext\\:\\ no\\ c\\/c\\/e\ \(0\)\
\-\ neuro\\:\\ 2\\+\\ dtrs\\ bilaterally\ \(0\)\
\-\ cbc\\:\\ 16\\.6\\/12\\.1\\/36\\.1\\/589\\ \\ ne\\ 81\\ \\ b8\ \(0\)\
\-\ bmp\\:\\ 133\\/3\\.6\\/94\\/30\\/11\\/0\\.7\\>119\\ \\ ca\\ 10\\.2\ \(0\)\
\-\ tp\\ 7\\.1\\ \\ alb\\ 4\\.0\ \(0\)\
\-\ ast\\ 10\\ \\ alt\\ 13\\ \\ alp\\ 76\\ \\ tbili\\ 0\\.3\ \(0\)\
\-\ ua\\:\\ le\\ small\\,\\ \\ 3\\ wbc\\,\\ 1\\ rbc\\ o\\/w\\ negative\ \(0\)\
\-\ bcx\\ \\(collected\\ 28jun\\)\\:\\ pending\ \(0\)\
\-\ uacx\\:\\ pending\ \(0\)\
\-\ 09jun\\	13jun\\	25jun\\	28jun\\	28jun\ \(0\)\
\-\ esr\\	105\\	99\\	91\\	98\\	93\ \(0\)\
\-\ 15jun\\	25jun\\	28jun\\	28jun\ \(0\)\
\-\ crp\\	8\\.01\\	8\\.87\\	7\\.62\\	8\\.58\ \(0\)\
\-\ previous\\ rheum\\ w\\/u\ \(0\)\
\-\ jo\\-1\\ extractable\\ nuclear\\ ab\\ \\<0\\.20\ \(0\)\
\-\ ribonucleoprotein\\ extractable\\ nuclear\\ ab\\ \\ 0\\.20\ \(0\)\
\-\ scl\\-70\\ extractable\\ nuclear\\ ab\\ \\ \\<0\\.20\ \(0\)\
\-\ ss\\-a\\ ab\\	\\ \\ \\<0\\.20\ \(0\)\
\-\ ss\\-b\\ ab\\	\\ \\<0\\.20\ \(0\)\
\-\ smith\\ extractable\\ nuclear\\ ab\\ \\ \\<0\\.20\\ \ \(0\)\
\-\ nuclear\\ ab\\ \\ negative\\ \ \(0\)\
\-\ anti\\-ccp\\ \\ negative\ \(0\)\
\-\ rheumatoid\\ factor\\ 10\\.2\ \(0\)\
\-\ 04jan\ \(0\)\
\-\ hba1c\\ \\ 5\\.7\ \(0\)\
\-\ she\\ was\\ initially\\ treated\\ with\\ broad\\ spectrum\\ antibiotics\\ which\\ consisted\\ of\\ ciprofloxacin\\ 400mg\\ iv\\ q12\\ vancomycin\\ 1000mg\\ q12\\ metronidazole\\ 500mg\\ iv\\ q6\\.\\ \\ she\\ had\\ drainage\\ and\\ culture\\ of\\ the\\ abscess\\ by\\ interventional\\ radiology\\,\\ were\\ they\\ removed\\ 60\\ ml\\ of\\ purulent\\ fluid\\.\\ \\ pt\\ culture\\ grew\\ fusobacterium\\ species\\ so\\ her\\ antibiotics\\ were\\ switched\\ to\\ ertapenem\\ 1gm\\ iv\\ daily\\.\\ \\ \ \(0\)\
\-\ she\\ was\\ discharged\\ from\\ the\\ hospital\\ with\\ a\\ picc\\ line\\ to\\ continue\\ iv\\ antibiotics\\ for\\ 6\\ weeks\\;\\ and\\,\\ with\\ a\\ drain\\ tube\\ in\\ place\\ per\\ ir\\ recommendation\\.\\ \\ the\\ drain\\ was\\ removed\\ two\\ weeks\\ later\\.\\ \\ pt\\ also\\ had\\ a\\ tee\\ because\\ of\\ her\\ new\\ murmur\\,\\ which\\ was\\ negative\\.\ \(0\)\
\-\ \\â\\€\\¢\\ ct\\:\\ ct\\ images\\ at\\ 5\\ mm\\ collimation\\ were\\ obtained\\ with\ \(0\)\
\-\ \\ oral\\ and\\ intravenous\\ contrast\\ material\\.\\ \ \(1\)\
\-\ the\\ findings\\ most\\ compatible\\ with\\ l5\\-s1\\ discitis\\/osteomyelitis\\ with\\ superior\\ s1\\ endplate\\ osteolysis\\.\\ \\ slight\\ widening\\ of\\ the\\ l5\\-\\ s1\\ intervertebral\\ disc\\ space\\.\\ \\ there\\ is\\ a\\ presacral\\ rim\\ enhancing\\ fluid\\ collection\\ measuring\\ a\\ 6\\.1\\ x\\ 4\\.2\\ x\\ 8\\.8\\ cm\\,\\ measuring\\ in\\ the\\ ap\\,\\ transverse\\ and\\ craniocaudal\\ dimensions\\,\\ respectively\\.\\ \\ this\\ fluid\\ collection\\ spans\\ from\\ the\\ level\\ of\\ the\\ mid\\ l5\\ vertebral\\ body\\ to\\ the\\ level\\ of\\ inferior\\ s3\\ vertebral\\ body\\.\\ \ \(0\)\
\-\ \\ \\-there\\ are\\ multilevel\\ degenerative\\ changes\\ of\\ the\\ lumbar\\ spine\\ with\\ vacuum\\ disk\\ phenomenon\\ at\\ l3\\ \\-\\-\\ l4\\ and\\ mild\\ disc\\ space\\ narrowing\\ at\\ this\\ level\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mri\\:impression\\:\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ diskitis\\ osteomyelitis\\ at\\ l5\\-s1\\ with\\ large\\ prevertebral\\ fluid\\ collection\\ \ \(0\)\
\-\ consistent\\ with\\ abscess\\.\\ \ \(2\)\
\-\ \\ \ \(1082074\)\
\-\ intermediate\\ signal\\ intensity\\ in\\ the\\ anterior\\ epidural\\ space\\ versus\\ within\\ epidural\\ venous\\ plexus\\ l5\\ to\\ s1\\.\\ \\ this\\ could\\ represent\\ a\\ small\\ subdural\\ abscess\\ versus\\ phlegmonous\\ change\\;\\ differential\\ \\ within\\ epidural\\ venous\\ plexus\\.\ \(0\)\
\-\ vertebral\\ osteomyelitis\\ and\\ diskitis\\ with\\ presacral\\ abscess\ \(0\)\
\-\ multiple\\ myeloma\ \(25\)\
\-\ diskitis\\/osteomyletis\ \(0\)\
\-\ metastatic\\ spinal\\ lesion\\ \ \(0\)\
\-\ degenerative\\ spinal\\ disease\\ \ \(0\)\
\-\ subdural\\ abscess\\ \ \(1\)\
\-\ compression\\ fracture\ \(49\)\
\-\ subdural\\ abscess\ \(2\)\
\-\ presacral\\ abscess\ \(2\)\
\-\ vacuum\\ disk\\ phenomenon\ \(2\)\
\-\ 62\\ y\\/o\\ woman\\ presented\\ to\\ the\\ ed\\ with\\ progressively\\ worsening\\ back\\ pain\\ for\\ six\\ weeks\\.\\ she\\ remembers\\ straining\\ her\\ back\\ when\\ she\\ was\\ gardening\\.\\ she\\ treated\\ herself\\ with\\ motrin\\,\\ but\\ because\\ of\\ a\\ planned\\ shoulder\\ surgery\\ went\\ to\\ her\\ pcm\\ \\(knowing\\ she\\â\\€\\™d\\ have\\ to\\ stop\\ the\\ nsaids\\)\\ and\\ was\\ switched\\ to\\ percocet\\ which\\ seemed\\ to\\ help\\.\\ her\\ shoulder\\ surgery\\ went\\ well\\,\\ but\\ she\\ notes\\ worsening\\ back\\ pain\\ ever\\ since\\ then\\ especially\\ over\\ the\\ last\\ two\\ weeks\\.\ \(0\)\
\-\ she\\ went\\ to\\ the\\ ed\\ multiple\\ times\\ for\\ severe\\ pain\\ and\\ at\\ least\\ once\\ three\\ weeks\\ ago\\ she\\ was\\ noted\\ to\\ have\\ fever\\ of\\ 102\\ as\\ well\\ as\\ an\\ elevated\\ esr\\ \\(105\\)\\.\\ she\\ was\\ presumptively\\ diagnosed\\ with\\ pmr\\ and\\ started\\ on\\ prednisone\\ and\\ referred\\ to\\ rheumatology\\.\\ she\\ was\\ seen\\ by\\ both\\ family\\ medicine\\ and\\ rheumatology\\ who\\ agreed\\ she\\ likely\\ did\\ not\\ have\\ pmr\\ and\\ the\\ steroids\\ were\\ discontinued\\,\\ however\\ she\\ continued\\ to\\ have\\ progressive\\ lower\\ back\\ pain\\ now\\ with\\ intermittent\\ radicular\\ symptoms\\.\\ an\\ mri\\ was\\ ordered\\ to\\ be\\ done\\ routinely\\ as\\ an\\ outpatient\\.\\ she\\ denies\\ weakness\\,\\ saddle\\ anesthesia\\,\\ fecal\\ or\\ urinary\\ incontinence\\,\\ rashes\\,\\ joint\\ pain\\,\\ or\\ n\\/v\\/d\\.\ \(0\)\
\-\ this\\ case\\ is\\ unique\\ because\\ of\\ the\\ bacterial\\ cause\\ of\\ her\\ osteomyelitis\\.\\ patients\\ abscess\\ was\\ cultured\\ and\\ shown\\ to\\ grow\\ fusobacterium\\ spp\\.\\ fusobacterium\\ is\\ a\\ gram\\-negative\\,\\ nonmotile\\ non\\-sporeforming\\,\\ obligate\\ anaerobic\\ rods\\ belonging\\ to\\ the\\ family\\ bacteroidacecae\\.\\ according\\ to\\ some\\ journals\\ there\\ has\\ been\\ only\\ 12\\ cases\\ of\\ fusobacteria\\ causing\\ diskitis\\ in\\ medical\\ literature\\.\\ \\ factors\\ associated\\ with\\ fusobacterial\\ infection\\ include\\ disruption\\ of\\ the\\ normal\\ cutaneous\\ and\\ mucocutaneous\\ barriers\\,\\ tissue\\ injury\\,\\ and\\ impaired\\ blood\\ supply\\ leading\\ to\\ hypoxia\\.\\ a\\ previous\\ ear\\â\\€\\“nose\\â\\€\\“throat\\ \\(ent\\)\\ infection\\ or\\ maxillofacial\\ problem\\ was\\ found\\ in\\ the\\ majority\\ of\\ the\\ patients\\ \\(n\\=8\\,\\ 73\\%\\)\\ without\\ any\\ other\\ identified\\ portal\\ of\\ entry\\.\\ this\\ pt\\ did\\ not\\ have\\ any\\ oral\\ associated\\ procedures\\ or\\ infection\\ but\\ she\\ did\\ have\\ shoulder\\ surgery\\ which\\ during\\ anesthesia\\ may\\ have\\ disrupted\\ normal\\ mucocutaneous\\ barrier\\.\\ \\ pt\\ did\\ also\\ complain\\ of\\ mild\\ back\\ pain\\ before\\ her\\ shoulder\\ surgery\\.\\ \\ the\\ clinical\\ and\\ radiological\\ presentations\\ for\\ osteomyletis\\ caused\\ by\\ fusobacterium\\ include\\ localized\\ pain\\ and\\ classical\\ signs\\ of\\ vertebral\\ osteomyelitis\\.\\ back\\ pain\\ and\\ fever\\ were\\ present\\ for\\ a\\ majority\\ of\\ patients\\ \\(n\\=10\\,\\ 91\\%\\)\\.\\ back\\ pain\\ was\\ present\\ in\\ our\\ pt\\ and\\ at\\ least\\ one\\ episode\\ of\\ fever\\ along\\ with\\ radicular\\ pain\\.\\ thirty\\ years\\ ago\\,\\ almost\\ all\\ fusobacteria\\ were\\ susceptible\\ to\\ metronidazole\\,\\ penicillin\\ g\\,\\ clindamycin\\,\\ cefoxitin\\,\\ chloramphenicol\\ but\\ were\\ resistant\\ to\\ vancomycin\\,\\ aminoglycosid\\ and\\ erythromycin\\.\\ recently\\,\\ increasing\\ numbers\\ of\\ strains\\ have\\ been\\ found\\ to\\ be\\ resistant\\ to\\ some\\ of\\ these\\ drugs\\,\\ in\\ particular\\ to\\ b\\-lactam\\ by\\ enzymatic\\ production\\.\\ fusobacteria\\ vertebral\\ osteomylitis\\ does\\ not\\ seem\\ to\\ increase\\ the\\ length\\ of\\ antiobiotic\\ treatment\\.\\ \\ \\ fusobacteria\\ species\\ causing\\ vertebral\\ osteomyelitis\\ seems\\ to\\ be\\ extremely\\ uncommon\\.\\ nevertheless\\ the\\ diagnosis\\ might\\ be\\ underestimated\\ because\\ of\\ difficulties\\ to\\ isolate\\ these\\ bacteria\\.\\ these\\ bacteria\\ should\\ be\\ considered\\ when\\ the\\ infection\\ does\\ not\\ respond\\ to\\ standard\\ therapy\\.\ \(0\)\
\-\ reference\\:\ \(0\)\
\-\ 1\\.\\	le\\ moal\\ g\\,\\ juhel\\ l\\,\\ grollier\\ g\\,\\ godet\\ c\\,\\ azais\\ i\\,\\ roblot\\ f\\.\\ vertebral\\ osteomyelitis\\ due\\ to\\ fusobacterium\\ species\\:\\ report\\ of\\ three\\ cases\\ and\\ review\\ of\\ the\\ literature\\.\\ \\ journal\\ of\\ infection\\.\\ 2005\\ aug\\;51\\(2\\)\\:e5\\-9\\.\ \(0\)\
\-\ 2\\.\\	bennett\\ kw\\,\\ eley\\ a\\.\\ fusobacteria\\:\\ new\\ taxonomy\\ and\\ related\\ diseases\\.\\ j\\ med\\ microbiol\\ 1993\\;39\\:246\\â\\€\\“54\\.\ \(0\)\
\-\ 3\\.\\	rubin\\ mm\\,\\ sanfilippo\\ rj\\,\\ sadoff\\ rs\\.\\ vertebral\\ osteomyelitis\\ secondary\\ to\\ an\\ oral\\ infection\\.\\ j\\ oral\\ maxillofac\\ surg\\ 1991\\;\\ 49\\:897\\â\\€\\“900\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ 0\\.20\\:\\ 0\\.04760856034545364\ \(0\)\
\-\ 28jun\\:\\ 0\\.03967380028787803\ \(0\)\
\-\ fusobacteria\\:\\ 0\\.03967380028787803\ \(0\)\
\-\ ab\\:\\ 0\\.03636091080441181\ \(0\)\
\-\ she\\:\\ 0\\.034545975034443524\ \(0\)\
\-\ fusobacterium\\:\\ 0\\.03243060536243204\ \(0\)\
\-\ extractable\\:\\ 0\\.031739040230302426\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.02502188961526134\ \(0\)\
\-\ vertebral\\:\\ 0\\.02435136936390465\ \(0\)\
\-\ back\\:\\ 0\\.02029930754525636\ \(0\)\
\-\ nuclear\\:\\ 0\\.019841580453205422\ \(0\)\
\-\ abscess\\:\\ 0\\.019455166474414164\ \(0\)\
\-\ \\:\\:\\ 0\\.01932963231667204\ \(0\)\
\-\ species\\:\\ 0\\.017871180503952148\ \(0\)\
\-\ her\\:\\ 0\\.01618891233968906\ \(0\)\
\-\ 25jun\\:\\ 0\\.015869520115151213\ \(0\)\
\-\ \\-subdural\\:\\ 0\\.015869520115151213\ \(0\)\
\-\ pmr\\:\\ 0\\.015869520115151213\ \(0\)\
\-\ \\<\\:\\ 0\\.014842779151673225\ \(0\)\
\-\ mucocutaneous\\:\\ 0\\.014621730411172911\ \(0\)\
\-\ pt\\:\\ 0\\.01429866676252364\ \(0\)\
\-\ presacral\\:\\ 0\\.013891820225559655\ \(0\)\
\-\ negative\\:\\ 0\\.013782827154139735\ \(0\)\
\-\ g\\:\\ 0\\.013648024234760402\ \(0\)\
\-\ infection\\:\\ 0\\.013415031003093467\ \(0\)\
\-\ q12\\:\\ 0\\.013373940707194613\ \(0\)\
\-\ have\\:\\ 0\\.013324486612889949\ \(0\)\
\-\ oral\\:\\ 0\\.012963393938280872\ \(0\)\
\-\ diskitis\\:\\ 0\\.012644030521581355\ \(0\)\
\-\ shoulder\\:\\ 0\\.012402809705990406\ \(0\)\
\-\ 10\\.2\\:\\ 0\\.012366531547994932\ \(0\)\
\-\ went\\:\\ 0\\.012293893466044599\ \(0\)\
\-\ were\\:\\ 0\\.012225026423788882\ \(0\)\
\-\ s1\\:\\ 0\\.011904948271923253\ \(0\)\
\-\ switched\\:\\ 0\\.011724452440994513\ \(0\)\
\-\ was\\:\\ 0\\.01156400341024116\ \(0\)\
\-\ to\\:\\ 0\\.011531992127173346\ \(0\)\
\-\ metronidazole\\:\\ 0\\.011396240817603055\ \(0\)\
\-\ epidural\\:\\ 0\\.011369077150256724\ \(0\)\
\-\ rheumatology\\:\\ 0\\.011252149534662395\ \(0\)\
\-\ iv\\:\\ 0\\.011227452520111949\ \(0\)\
\-\ did\\:\\ 0\\.011108617969371463\ \(0\)\
\-\ weeks\\:\\ 0\\.010914841390194188\ \(0\)\
\-\ because\\:\\ 0\\.010763342273937165\ \(0\)\
\-\ \\,\\:\\ 0\\.010721190713555937\ \(0\)\
\-\ 91\\:\\ 0\\.010568999900630167\ \(0\)\
\-\ vancomycin\\:\\ 0\\.010568999900630167\ \(0\)\
\-\ 105\\:\\ 0\\.010476662737016213\ \(0\)\
\-\ resistant\\:\\ 0\\.010388831658403375\ \(0\)\
\-\ anesthesia\\:\\ 0\\.010225066081075335\ \(0\)\
\-\ phenomenon\\:\\ 0\\.010074964174794414\ \(0\)\
\-\ radicular\\:\\ 0\\.009870952140038332\ \(0\)\
\-\ collection\\:\\ 0\\.00976693445373719\ \(0\)\
\-\ le\\:\\ 0\\.009746752551402955\ \(0\)\
\-\ bacteria\\:\\ 0\\.009746752551402955\ \(0\)\
\-\ pain\\:\\ 0\\.00939341284906152\ \(0\)\
\-\ \\;\\:\\ 0\\.009115306878724545\ \(0\)\
\-\ l5\\-s1\\:\\ 0\\.008977276377097035\ \(0\)\
\-\ fluid\\:\\ 0\\.00874397517409128\ \(0\)\
\-\ antibiotics\\:\\ 0\\.008667100875797933\ \(0\)\
\-\ l5\\:\\ 0\\.008623162436060034\ \(0\)\
\-\ drain\\:\\ 0\\.00846920712834057\ \(0\)\
\-\ disk\\:\\ 0\\.008327387366228753\ \(0\)\
\-\ literature\\:\\ 0\\.008273646658488553\ \(0\)\
\-\ culture\\:\\ 0\\.008195928977363065\ \(0\)\
\-\ murmur\\:\\ 0\\.007958720556784985\ \(0\)\
\-\ rusb\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ faber\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 16\\.6\\/12\\.1\\/36\\.1\\/589\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ b8\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 133\\/3\\.6\\/94\\/30\\/11\\/0\\.7\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ uacx\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 09jun\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 13jun\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 15jun\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 8\\.01\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 8\\.87\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 7\\.62\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 8\\.58\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ jo\\-1\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ ribonucleoprotein\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ scl\\-70\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ ss\\-a\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ ss\\-b\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ anti\\-ccp\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 04jan\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 400mg\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 1000mg\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ ertapenem\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 1gm\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ l5\\-\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ \\-diskitis\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ \\-intermediate\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ \\-diskitis\\/osteomyletis\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ \\-presacral\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ \\-vacuum\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ gardening\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ presumptively\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ spp\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ nonmotile\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ non\\-sporeforming\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ obligate\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ belonging\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ bacteroidacecae\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ journals\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ fusobacterial\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ ear\\â\\€\\“nose\\â\\€\\“throat\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ n\\=8\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ osteomyletis\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ n\\=10\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ cefoxitin\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ chloramphenicol\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ aminoglycosid\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ enzymatic\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ moal\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ juhel\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ grollier\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ godet\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ azais\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ roblot\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ e5\\-9\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ eley\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ microbiol\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 39\\:246\\â\\€\\“54\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ rubin\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ sanfilippo\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ sadoff\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ maxillofac\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ 49\\:897\\â\\€\\“900\\:\\ 0\\.007934760057575607\ \(0\)\
\-\ fever\\:\\ 0\\.0078071898106713755\ \(0\)\
\-\ esr\\:\\ 0\\.007789166614283274\ \(0\)\
\-\ least\\:\\ 0\\.007710025077971632\ \(0\)\
\-\ space\\:\\ 0\\.007632467165823496\ \(0\)\
\-\ majority\\:\\ 0\\.007561472380063435\ \(0\)\
\-\ plexus\\:\\ 0\\.0074744902427622524\ \(0\)\
\-\ surgery\\:\\ 0\\.007470743706067596\ \(0\)\
\-\ versus\\:\\ 0\\.0073122020393521754\ \(0\)\
\-\ iii\\/vi\\:\\ 0\\.007310865205586456\ \(0\)\
\-\ ne\\:\\ 0\\.007310865205586456\ \(0\)\
\-\ tp\\:\\ 0\\.007310865205586456\ \(0\)\
\-\ bcx\\:\\ 0\\.007310865205586456\ \(0\)\
\-\ spans\\:\\ 0\\.007310865205586456\ \(0\)\
\-\ \\-compression\\:\\ 0\\.007310865205586456\ \(0\)\
\-\ b\\-lactam\\:\\ 0\\.007310865205586456\ \(0\)\
\-\ osteomylitis\\:\\ 0\\.007310865205586456\ \(0\)\
\-\ isolate\\:\\ 0\\.007310865205586456\ \(0\)\
\-\ kw\\:\\ 0\\.007310865205586456\ \(0\)\
\-\ taxonomy\\:\\ 0\\.007310865205586456\ \(0\)\
\-\ at\\:\\ 0\\.007294637326571945\ \(0\)\
\-\ disc\\:\\ 0\\.007163342064833519\ \(0\)\
\-\ j\\:\\ 0\\.006948139273384765\ \(0\)\
\-\ hba1c\\:\\ 0\\.006945910112779828\ \(0\)\
\-\ q6\\:\\ 0\\.006945910112779828\ \(0\)\
\-\ \\-degenerative\\:\\ 0\\.006945910112779828\ \(0\)\
\-\ n\\/v\\/d\\:\\ 0\\.006945910112779828\ \(0\)\
\-\ barriers\\:\\ 0\\.006945910112779828\ \(0\)\
\-\ antiobiotic\\:\\ 0\\.006945910112779828\ \(0\)\
\-\ underestimated\\:\\ 0\\.006945910112779828\ \(0\)\
\-\ removed\\:\\ 0\\.006935506379309795\ \(0\)\
\-\ alp\\:\\ 0\\.006686970353597306\ \(0\)\
\-\ o\\/w\\:\\ 0\\.006686970353597306\ \(0\)\
\-\ discitis\\/osteomyelitis\\:\\ 0\\.006686970353597306\ \(0\)\
\-\ \\-there\\:\\ 0\\.006686970353597306\ \(0\)\
\-\ maxillofacial\\:\\ 0\\.006686970353597306\ \(0\)\
\-\ penicillin\\:\\ 0\\.006686970353597306\ \(0\)\
\-\ strains\\:\\ 0\\.006686970353597306\ \(0\)\
\-\ pending\\:\\ 0\\.006656209921781716\ \(0\)\
\-\ level\\:\\ 0\\.006650465421188835\ \(0\)\
\-\ causing\\:\\ 0\\.006645462546468477\ \(0\)\
\-\ but\\:\\ 0\\.006561668050525788\ \(0\)\
\-\ ed\\:\\ 0\\.006501371263527817\ \(0\)\
\-\ rheum\\:\\ 0\\.006486121072486407\ \(0\)\
\-\ w\\/u\\:\\ 0\\.006486121072486407\ \(0\)\
\-\ 500mg\\:\\ 0\\.006486121072486407\ \(0\)\
\-\ tee\\:\\ 0\\.006486121072486407\ \(0\)\
\-\ knowing\\:\\ 0\\.006486121072486407\ \(0\)\
\-\ erythromycin\\:\\ 0\\.006486121072486407\ \(0\)\
\-\ rs\\:\\ 0\\.006486121072486407\ \(0\)\
\-\ blowing\\:\\ 0\\.0063220152607906775\ \(0\)\
\-\ 8\\.8\\:\\ 0\\.0063220152607906775\ \(0\)\
\-\ phlegmonous\\:\\ 0\\.0063220152607906775\ \(0\)\
\-\ percocet\\:\\ 0\\.0063220152607906775\ \(0\)\
\-\ agreed\\:\\ 0\\.0063220152607906775\ \(0\)\
\-\ gram\\-negative\\:\\ 0\\.0063220152607906775\ \(0\)\
\-\ family\\:\\ 0\\.006304792880152494\ \(0\)\
\-\ c\\/c\\/e\\:\\ 0\\.006183265773997466\ \(0\)\
\-\ 119\\:\\ 0\\.006183265773997466\ \(0\)\
\-\ 7\\.1\\:\\ 0\\.006183265773997466\ \(0\)\
\-\ collected\\:\\ 0\\.006183265773997466\ \(0\)\
\-\ ciprofloxacin\\:\\ 0\\.006183265773997466\ \(0\)\
\-\ collimation\\:\\ 0\\.006183265773997466\ \(0\)\
\-\ remembers\\:\\ 0\\.006183265773997466\ \(0\)\
\-\ straining\\:\\ 0\\.006183265773997466\ \(0\)\
\-\ herself\\:\\ 0\\.006183265773997466\ \(0\)\
\-\ clindamycin\\:\\ 0\\.006183265773997466\ \(0\)\
\-\ measuring\\:\\ 0\\.006151855485956337\ \(0\)\
\-\ w\\/r\\/r\\:\\ 0\\.006063075501608156\ \(0\)\
\-\ nt\\/nd\\:\\ 0\\.006063075501608156\ \(0\)\
\-\ 5\\.7\\:\\ 0\\.006063075501608156\ \(0\)\
\-\ cultured\\:\\ 0\\.006063075501608156\ \(0\)\
\-\ anaerobic\\:\\ 0\\.006063075501608156\ \(0\)\
\-\ worsening\\:\\ 0\\.006056669613682804\ \(0\)\
\-\ these\\:\\ 0\\.006004981166402809\ \(0\)\
\-\ previous\\:\\ 0\\.005973627720383972\ \(0\)\
\-\ patients\\:\\ 0\\.005971848603148585\ \(0\)\
\-\ nabs\\:\\ 0\\.005957060167984049\ \(0\)\
\-\ \\-multiple\\:\\ 0\\.005957060167984049\ \(0\)\
\-\ motrin\\:\\ 0\\.005957060167984049\ \(0\)\
\-\ saddle\\:\\ 0\\.005957060167984049\ \(0\)\
\-\ numbers\\:\\ 0\\.005957060167984049\ \(0\)\
\-\ aug\\:\\ 0\\.005957060167984049\ \(0\)\
\-\ bennett\\:\\ 0\\.005957060167984049\ \(0\)\
\-\ be\\:\\ 0\\.005930498304878169\ \(0\)\
\-\ \\-the\\:\\ 0\\.005862226220497257\ \(0\)\
\-\ 6\\.1\\:\\ 0\\.005862226220497257\ \(0\)\
\-\ vacuum\\:\\ 0\\.005862226220497257\ \(0\)\
\-\ pcm\\:\\ 0\\.005862226220497257\ \(0\)\
\-\ ever\\:\\ 0\\.005862226220497257\ \(0\)\
\-\ routinely\\:\\ 0\\.005776438479899304\ \(0\)\
\-\ entry\\:\\ 0\\.005776438479899304\ \(0\)\
\-\ nevertheless\\:\\ 0\\.005776438479899304\ \(0\)\
\-\ which\\:\\ 0\\.005743094823555531\ \(0\)\
\-\ ago\\:\\ 0\\.005725884465881635\ \(0\)\
\-\ alb\\:\\ 0\\.0056981204088015274\ \(0\)\
\-\ 4\\.0\\:\\ 0\\.0056981204088015274\ \(0\)\
\-\ rods\\:\\ 0\\.0056981204088015274\ \(0\)\
\-\ presentations\\:\\ 0\\.0056981204088015274\ \(0\)\
\-\ thirty\\:\\ 0\\.0056981204088015274\ \(0\)\
\-\ rj\\:\\ 0\\.0056981204088015274\ \(0\)\
\-\ mm\\:\\ 0\\.005656516933924402\ \(0\)\
\-\ carotids\\:\\ 0\\.005626074767331198\ \(0\)\
\-\ dtrs\\:\\ 0\\.005626074767331198\ \(0\)\
\-\ 0\\.3\\:\\ 0\\.005626074767331198\ \(0\)\
\-\ s3\\:\\ 0\\.005626074767331198\ \(0\)\
\-\ susceptible\\:\\ 0\\.005626074767331198\ \(0\)\
\-\ venous\\:\\ 0\\.005583772490471879\ \(0\)\
\-\ osteolysis\\:\\ 0\\.005559370922008316\ \(0\)\
\-\ seem\\:\\ 0\\.005559370922008316\ \(0\)\
\-\ spinal\\:\\ 0\\.005508147993482603\ \(0\)\
\-\ 93\\:\\ 0\\.005497271127690628\ \(0\)\
\-\ \\-metastatic\\:\\ 0\\.005497271127690628\ \(0\)\
\-\ seemed\\:\\ 0\\.005497271127690628\ \(0\)\
\-\ discontinued\\:\\ 0\\.005497271127690628\ \(0\)\
\-\ fecal\\:\\ 0\\.005497271127690628\ \(0\)\
\-\ barrier\\:\\ 0\\.005497271127690628\ \(0\)\
\-\ ir\\:\\ 0\\.005439180649619007\ \(0\)\
\-\ multilevel\\:\\ 0\\.005439180649619007\ \(0\)\
\-\ classical\\:\\ 0\\.005439180649619007\ \(0\)\
\-\ consisted\\:\\ 0\\.005384613033222576\ \(0\)\
\-\ recommendation\\:\\ 0\\.005384613033222576\ \(0\)\
\-\ new\\:\\ 0\\.005360554413682373\ \(0\)\
\-\ ml\\:\\ 0\\.0053331653159948995\ \(0\)\
\-\ picc\\:\\ 0\\.0053331653159948995\ \(0\)\
\-\ 102\\:\\ 0\\.0053331653159948995\ \(0\)\
\-\ 1991\\:\\ 0\\.0053331653159948995\ \(0\)\
\-\ jvd\\:\\ 0\\.005284499950315083\ \(0\)\
\-\ endplate\\:\\ 0\\.005284499950315083\ \(0\)\
\-\ 4\\.2\\:\\ 0\\.005284499950315083\ \(0\)\
\-\ rashes\\:\\ 0\\.005284499950315083\ \(0\)\
\-\ 1993\\:\\ 0\\.005284499950315083\ \(0\)\
\-\ does\\:\\ 0\\.005248642790970309\ \(0\)\
\-\ dimensions\\:\\ 0\\.0052383313685081066\ \(0\)\
\-\ well\\:\\ 0\\.0052198405570710645\ \(0\)\
\-\ tbili\\:\\ 0\\.005194415829201687\ \(0\)\
\-\ disrupted\\:\\ 0\\.005194415829201687\ \(0\)\
\-\ three\\:\\ 0\\.005185642175241962\ \(0\)\
\-\ purulent\\:\\ 0\\.005152543627910155\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.005152543627910155\ \(0\)\
\-\ cases\\:\\ 0\\.005124772032369275\ \(0\)\
\-\ by\\:\\ 0\\.005122847536435192\ \(0\)\
\-\ pulm\\:\\ 0\\.005112533040537668\ \(0\)\
\-\ prevertebral\\:\\ 0\\.005112533040537668\ \(0\)\
\-\ stop\\:\\ 0\\.005112533040537668\ \(0\)\
\-\ seems\\:\\ 0\\.005112533040537668\ \(0\)\
\-\ respond\\:\\ 0\\.005112533040537668\ \(0\)\
\-\ x\\:\\ 0\\.00507482688631409\ \(0\)\
\-\ bmp\\:\\ 0\\.005074225556812378\ \(0\)\
\-\ notes\\:\\ 0\\.005074225556812378\ \(0\)\
\-\ bilaterally\\:\\ 0\\.005052574686811707\ \(0\)\
\-\ 81\\:\\ 0\\.0050021799153420485\ \(0\)\
\-\ grow\\:\\ 0\\.0050021799153420485\ \(0\)\
\-\ f\\.\\:\\ 0\\.0050021799153420485\ \(0\)\
\-\ body\\:\\ 0\\.004995974280268379\ \(0\)\
\-\ grew\\:\\ 0\\.004968210223188271\ \(0\)\
\-\ impaired\\:\\ 0\\.004968210223188271\ \(0\)\
\-\ difficulties\\:\\ 0\\.004968210223188271\ \(0\)\
\-\ unique\\:\\ 0\\.004903890723654387\ \(0\)\
\-\ hypoxia\\:\\ 0\\.004873376275701478\ \(0\)\
\-\ found\\:\\ 0\\.004847930899103712\ \(0\)\
\-\ any\\:\\ 0\\.004843987458275956\ \(0\)\
\-\ 99\\:\\ 0\\.004815285797629857\ \(0\)\
\-\ complain\\:\\ 0\\.004815285797629857\ \(0\)\
\-\ ctab\\:\\ 0\\.004760718181233426\ \(0\)\
\-\ 98\\:\\ 0\\.004760718181233426\ \(0\)\
\-\ intervertebral\\:\\ 0\\.004734626788908266\ \(0\)\
\-\ 73\\:\\ 0\\.004734626788908266\ \(0\)\
\-\ ext\\:\\ 0\\.00470927046400575\ \(0\)\
\-\ crp\\:\\ 0\\.00470927046400575\ \(0\)\
\-\ some\\:\\ 0\\.004671337990759242\ \(0\)\
\-\ production\\:\\ 0\\.004660605098325934\ \(0\)\
\-\ interventional\\:\\ 0\\.004614436516518957\ \(0\)\
\-\ l3\\:\\ 0\\.004614436516518957\ \(0\)\
\-\ ent\\:\\ 0\\.004614436516518957\ \(0\)\
\-\ treated\\:\\ 0\\.004604591964147361\ \(0\)\
\-\ surg\\:\\ 0\\.0045922109426302345\ \(0\)\
\-\ \\(\\:\\ 0\\.004551334008737195\ \(0\)\
\-\ heard\\:\\ 0\\.0045493414115868\ \(0\)\
\-\ l4\\:\\ 0\\.0045493414115868\ \(0\)\
\-\ prednisone\\:\\ 0\\.0045493414115868\ \(0\)\
\-\ incontinence\\:\\ 0\\.0045493414115868\ \(0\)\
\-\ \\)\\:\\ 0\\.004495737034017224\ \(0\)\
\-\ myeloma\\:\\ 0\\.004469280668097606\ \(0\)\
\-\ cutaneous\\:\\ 0\\.004469280668097606\ \(0\)\
\-\ spectrum\\:\\ 0\\.004450330704823229\ \(0\)\
\-\ radiological\\:\\ 0\\.004450330704823229\ \(0\)\
\-\ not\\:\\ 0\\.004445791797450712\ \(0\)\
\-\ rbc\\:\\ 0\\.004431771490419326\ \(0\)\
\-\ respectively\\:\\ 0\\.004431771490419326\ \(0\)\
\-\ med\\:\\ 0\\.004413587235408058\ \(0\)\
\-\ two\\:\\ 0\\.004405636791387949\ \(0\)\
\-\ when\\:\\ 0\\.004405636791387949\ \(0\)\
\-\ raise\\:\\ 0\\.0043782850633528984\ \(0\)\
\-\ planned\\:\\ 0\\.0043782850633528984\ \(0\)\
\-\ outpatient\\:\\ 0\\.0043782850633528984\ \(0\)\
\-\ extremely\\:\\ 0\\.0043782850633528984\ \(0\)\
\-\ ttp\\:\\ 0\\.004361139973370276\ \(0\)\
\-\ might\\:\\ 0\\.004361139973370276\ \(0\)\
\-\ journal\\:\\ 0\\.004361139973370276\ \(0\)\
\-\ 76\\:\\ 0\\.004344315371199121\ \(0\)\
\-\ this\\:\\ 0\\.00432555001491509\ \(0\)\
\-\ include\\:\\ 0\\.004315307809235439\ \(0\)\
\-\ a\\.\\:\\ 0\\.004311581218030017\ \(0\)\
\-\ systolic\\:\\ 0\\.004279995871665237\ \(0\)\
\-\ smith\\:\\ 0\\.004279995871665237\ \(0\)\
\-\ according\\:\\ 0\\.004279995871665237\ \(0\)\
\-\ supply\\:\\ 0\\.004279995871665237\ \(0\)\
\-\ nad\\:\\ 0\\.004264609342988999\ \(0\)\
\-\ cv\\:\\ 0\\.004264609342988999\ \(0\)\
\-\ an\\:\\ 0\\.0042544189533203595\ \(0\)\
\-\ compatible\\:\\ 0\\.004249481423712329\ \(0\)\
\-\ drugs\\:\\ 0\\.004249481423712329\ \(0\)\
\-\ gen\\:\\ 0\\.004234603564170285\ \(0\)\
\-\ 62\\:\\ 0\\.004205565884405909\ \(0\)\
\-\ problem\\:\\ 0\\.004205565884405909\ \(0\)\
\-\ been\\:\\ 0\\.00418504930596578\ \(0\)\
\-\ ast\\:\\ 0\\.004177435782241999\ \(0\)\
\-\ alt\\:\\ 0\\.004177435782241999\ \(0\)\
\-\ 51\\:\\ 0\\.004177435782241999\ \(0\)\
\-\ subdural\\:\\ 0\\.004163693683114376\ \(0\)\
\-\ procedures\\:\\ 0\\.004163693683114376\ \(0\)\
\-\ continue\\:\\ 0\\.0041501582399419736\ \(0\)\
\-\ nsaids\\:\\ 0\\.0041501582399419736\ \(0\)\
\-\ 2005\\:\\ 0\\.0041501582399419736\ \(0\)\
\-\ progressively\\:\\ 0\\.004136823329244276\ \(0\)\
\-\ reference\\:\\ 0\\.004136823329244276\ \(0\)\
\-\ particular\\:\\ 0\\.004123683095741889\ \(0\)\
\-\ straight\\:\\ 0\\.004110731936919117\ \(0\)\
\-\ impression\\:\\ 0\\.004110731936919117\ \(0\)\
\-\ ua\\:\\ 0\\.0040853756120166\ \(0\)\
\-\ abd\\:\\ 0\\.004072960380574354\ \(0\)\
\-\ mild\\:\\ 0\\.004050861303206367\ \(0\)\
\-\ portal\\:\\ 0\\.00404863214260143\ \(0\)\
\-\ broad\\:\\ 0\\.003990541664529807\ \(0\)\
\-\ daily\\:\\ 0\\.003979360278392493\ \(0\)\
\-\ neuro\\:\\ 0\\.003968316090641084\ \(0\)\
\-\ 2\\+\\:\\ 0\\.003935974048133377\ \(0\)\
\-\ once\\:\\ 0\\.003935974048133377\ \(0\)\
\-\ bacterial\\:\\ 0\\.003935974048133377\ \(0\)\
\-\ standard\\:\\ 0\\.003935974048133377\ \(0\)\
\-\ rrr\\:\\ 0\\.00392544655959765\ \(0\)\
\-\ factor\\:\\ 0\\.00392544655959765\ \(0\)\
\-\ widening\\:\\ 0\\.0038745804837530587\ \(0\)\
\-\ diseases\\:\\ 0\\.0038745804837530587\ \(0\)\
\-\ no\\:\\ 0\\.003872385916758785\ \(0\)\
\-\ length\\:\\ 0\\.003855012538985816\ \(0\)\
\-\ d\\:\\ 0\\.0038358609652258844\ \(0\)\
\-\ help\\:\\ 0\\.0038358609652258844\ \(0\)\
\-\ intravenous\\:\\ 0\\.0038171084117579798\ \(0\)\
\-\ episode\\:\\ 0\\.0038078766384301763\ \(0\)\
\-\ six\\:\\ 0\\.0037807361900317176\ \(0\)\
\-\ uncommon\\:\\ 0\\.0037630868008432603\ \(0\)\
\-\ disruption\\:\\ 0\\.003745776844112489\ \(0\)\
\-\ localized\\:\\ 0\\.003745776844112489\ \(0\)\
\-\ place\\:\\ 0\\.0037372451213811262\ \(0\)\
\-\ times\\:\\ 0\\.0037287935099051227\ \(0\)\
\-\ almost\\:\\ 0\\.0037204205192099713\ \(0\)\
\-\ leading\\:\\ 0\\.0036796855132800697\ \(0\)\
\-\ our\\:\\ 0\\.0036561010196760877\ \(0\)\
\-\ c\\:\\ 0\\.0036561010196760877\ \(0\)\
\-\ medicine\\:\\ 0\\.0036483748777396416\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.0036331187496444362\ \(0\)\
\-\ associated\\:\\ 0\\.003629995610994963\ \(0\)\
\-\ slight\\:\\ 0\\.0036181169022230036\ \(0\)\
\-\ steroids\\:\\ 0\\.0036181169022230036\ \(0\)\
\-\ ordered\\:\\ 0\\.0036181169022230036\ \(0\)\
\-\ or\\:\\ 0\\.0036058424805173986\ \(0\)\
\-\ recently\\:\\ 0\\.003588843102308008\ \(0\)\
\-\ \\%\\:\\ 0\\.003588336693692183\ \(0\)\
\-\ ca\\:\\ 0\\.0035816710324167596\ \(0\)\
\-\ a\\:\\ 0\\.0035697551918866003\ \(0\)\
\-\ and\\:\\ 0\\.003564534766974623\ \(0\)\
\-\ urinary\\:\\ 0\\.0035604914667910223\ \(0\)\
\-\ small\\:\\ 0\\.003543789890875101\ \(0\)\
\-\ mri\\:\\ 0\\.0035342499638427\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.0035330056667369435\ \(0\)\
\-\ discharged\\:\\ 0\\.003526263387952823\ \(0\)\
\-\ l\\:\\ 0\\.003506334381762712\ \(0\)\
\-\ so\\:\\ 0\\.0034997882437527396\ \(0\)\
\-\ as\\:\\ 0\\.0034903082967438193\ \(0\)\
\-\ degenerative\\:\\ 0\\.0034868370849299676\ \(0\)\
\-\ present\\:\\ 0\\.0034743631933963647\ \(0\)\
\-\ 13\\:\\ 0\\.0034740696366923826\ \(0\)\
\-\ factors\\:\\ 0\\.0034552517385651876\ \(0\)\
\-\ report\\:\\ 0\\.003442921545623548\ \(0\)\
\-\ cbc\\:\\ 0\\.003436819217103855\ \(0\)\
\-\ material\\:\\ 0\\.003436819217103855\ \(0\)\
\-\ started\\:\\ 0\\.003430757982017137\ \(0\)\
\-\ appearing\\:\\ 0\\.0034187566040968257\ \(0\)\
\-\ represent\\:\\ 0\\.0033779688487304512\ \(0\)\
\-\ per\\:\\ 0\\.003366646812540658\ \(0\)\
\-\ the\\:\\ 0\\.0033597935976578727\ \(0\)\
\-\ 60\\:\\ 0\\.003355465426403343\ \(0\)\
\-\ review\\:\\ 0\\.0033335109231412735\ \(0\)\
\-\ had\\:\\ 0\\.003319261600793354\ \(0\)\
\-\ continued\\:\\ 0\\.003312079196144227\ \(0\)\
\-\ intermittent\\:\\ 0\\.0033015517076085015\ \(0\)\
\-\ last\\:\\ 0\\.0032859878038190675\ \(0\)\
\-\ for\\:\\ 0\\.0032813148003722555\ \(0\)\
\-\ lumbar\\:\\ 0\\.003270688455152487\ \(0\)\
\-\ rim\\:\\ 0\\.0032556448179123965\ \(0\)\
\-\ before\\:\\ 0\\.0032556448179123965\ \(0\)\
\-\ radiology\\:\\ 0\\.0032506856317639087\ \(0\)\
\-\ denies\\:\\ 0\\.003245753619374507\ \(0\)\
\-\ tube\\:\\ 0\\.003240848484570218\ \(0\)\
\-\ best\\:\\ 0\\.0032359699359929554\ \(0\)\
\-\ caused\\:\\ 0\\.003226291455546275\ \(0\)\
\-\ increase\\:\\ 0\\.003226291455546275\ \(0\)\
\-\ drainage\\:\\ 0\\.0032167159396101312\ \(0\)\
\-\ mid\\:\\ 0\\.0032167159396101312\ \(0\)\
\-\ done\\:\\ 0\\.0031885858374462207\ \(0\)\
\-\ i\\:\\ 0\\.003179401165822241\ \(0\)\
\-\ related\\:\\ 0\\.0031748437383185986\ \(0\)\
\-\ especially\\:\\ 0\\.0031657975314297584\ \(0\)\
\-\ line\\:\\ 0\\.0031613082951461946\ \(0\)\
\-\ increasing\\:\\ 0\\.003152396440076247\ \(0\)\
\-\ 12\\:\\ 0\\.0031479733844484983\ \(0\)\
\-\ initially\\:\\ 0\\.003130495359374599\ \(0\)\
\-\ considered\\:\\ 0\\.0031048986579159735\ \(0\)\
\-\ transverse\\:\\ 0\\.0030841104357785753\ \(0\)\
\-\ narrowing\\:\\ 0\\.0030841104357785753\ \(0\)\
\-\ shown\\:\\ 0\\.0030841104357785753\ \(0\)\
\-\ progressive\\:\\ 0\\.0030399992034593182\ \(0\)\
\-\ in\\:\\ 0\\.003034363493359171\ \(0\)\
\-\ also\\:\\ 0\\.0030326185304593183\ \(0\)\
\-\ leg\\:\\ 0\\.003024480025750492\ \(0\)\
\-\ change\\:\\ 0\\.002997949136341893\ \(0\)\
\-\ within\\:\\ 0\\.002934529988093756\ \(0\)\
\-\ referred\\:\\ 0\\.0029023685359636734\ \(0\)\
\-\ hospital\\:\\ 0\\.0028956763861099216\ \(0\)\
\-\ weakness\\:\\ 0\\.0028565358713126773\ \(0\)\
\-\ could\\:\\ 0\\.002837585908038301\ \(0\)\
\-\ of\\:\\ 0\\.0028313254919403127\ \(0\)\
\-\ diagnosed\\:\\ 0\\.002828258466962201\ \(0\)\
\-\ since\\:\\ 0\\.0028251706765960545\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.0028209079236649645\ \(0\)\
\-\ ap\\:\\ 0\\.0028129243651147055\ \(0\)\
\-\ wbc\\:\\ 0\\.0028038477502932597\ \(0\)\
\-\ intensity\\:\\ 0\\.002780081616903061\ \(0\)\
\-\ later\\:\\ 0\\.0027771544923428657\ \(0\)\
\-\ they\\:\\ 0\\.0027713286467032456\ \(0\)\
\-\ identified\\:\\ 0\\.0027483951765853477\ \(0\)\
\-\ then\\:\\ 0\\.0027371439049703778\ \(0\)\
\-\ obtained\\:\\ 0\\.002734352925962054\ \(0\)\
\-\ signs\\:\\ 0\\.002706909031490598\ \(0\)\
\-\ 3\\.\\:\\ 0\\.002631749965923247\ \(0\)\
\-\ now\\:\\ 0\\.0026292669574272255\ \(0\)\
\-\ inferior\\:\\ 0\\.0026096456897921356\ \(0\)\
\-\ elevated\\:\\ 0\\.0026096456897921356\ \(0\)\
\-\ cause\\:\\ 0\\.002602396603557125\ \(0\)\
\-\ 10\\:\\ 0\\.002592821087620981\ \(0\)\
\-\ \\>\\:\\ 0\\.0025555063138330914\ \(0\)\
\-\ along\\:\\ 0\\.0025419026794406083\ \(0\)\
\-\ spine\\:\\ 0\\.0025329464860534183\ \(0\)\
\-\ radiation\\:\\ 0\\.0025240785324593487\ \(0\)\
\-\ joint\\:\\ 0\\.0024873350630441773\ \(0\)\
\-\ superior\\:\\ 0\\.0024561149388426565\ \(0\)\
\-\ injury\\:\\ 0\\.002452032890989019\ \(0\)\
\-\ should\\:\\ 0\\.002452032890989019\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0024459443220524375\ \(0\)\
\-\ differential\\:\\ 0\\.002441908037221359\ \(0\)\
\-\ enhancing\\:\\ 0\\.002412199399536237\ \(0\)\
\-\ normal\\:\\ 0\\.0024115435726356454\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0024025105007179125\ \(0\)\
\-\ severe\\:\\ 0\\.0023666154816075645\ \(0\)\
\-\ medical\\:\\ 0\\.0023666154816075645\ \(0\)\
\-\ clinical\\:\\ 0\\.0023666154816075645\ \(0\)\
\-\ during\\:\\ 0\\.0023537436993013574\ \(0\)\
\-\ only\\:\\ 0\\.002312701762812723\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.002298853951076018\ \(0\)\
\-\ 6\\:\\ 0\\.002297137859023289\ \(0\)\
\-\ there\\:\\ 0\\.0022893169333303123\ \(0\)\
\-\ from\\:\\ 0\\.0022798122649040726\ \(0\)\
\-\ years\\:\\ 0\\.0022585446777844127\ \(0\)\
\-\ 5\\:\\ 0\\.002250369417141461\ \(0\)\
\-\ changes\\:\\ 0\\.0022043636149730516\ \(0\)\
\-\ all\\:\\ 0\\.002175448685356697\ \(0\)\
\-\ likely\\:\\ 0\\.002169477917133804\ \(0\)\
\-\ ct\\:\\ 0\\.0021517617522809054\ \(0\)\
\-\ secondary\\:\\ 0\\.0021503420040583326\ \(0\)\
\-\ however\\:\\ 0\\.002141645414578821\ \(0\)\
\-\ y\\/o\\:\\ 0\\.0021301791447521515\ \(0\)\
\-\ blood\\:\\ 0\\.0020993799032486943\ \(0\)\
\-\ presented\\:\\ 0\\.0020966315346736355\ \(0\)\
\-\ one\\:\\ 0\\.0020843666816477446\ \(0\)\
\-\ cm\\:\\ 0\\.002062966802715559\ \(0\)\
\-\ therapy\\:\\ 0\\.002056382354852037\ \(0\)\
\-\ due\\:\\ 0\\.002052454683125868\ \(0\)\
\-\ signal\\:\\ 0\\.0020279696942149222\ \(0\)\
\-\ fracture\\:\\ 0\\.0020279696942149222\ \(0\)\
\-\ who\\:\\ 0\\.0020053721054380754\ \(0\)\
\-\ anterior\\:\\ 0\\.0019809116325497185\ \(0\)\
\-\ both\\:\\ 0\\.001964176409258435\ \(0\)\
\-\ over\\:\\ 0\\.00195827415854182\ \(0\)\
\-\ symptoms\\:\\ 0\\.00191688341755008\ \(0\)\
\-\ consistent\\:\\ 0\\.001885957037651848\ \(0\)\
\-\ 1\\:\\ 0\\.00183017674883862\ \(0\)\
\-\ noted\\:\\ 0\\.0018230613757449087\ \(0\)\
\-\ tissue\\:\\ 0\\.0018230613757449087\ \(0\)\
\-\ without\\:\\ 0\\.0018109929490172458\ \(0\)\
\-\ 3\\:\\ 0\\.00180105807984387\ \(0\)\
\-\ woman\\:\\ 0\\.0017766903217721927\ \(0\)\
\-\ most\\:\\ 0\\.001775729200475316\ \(0\)\
\-\ other\\:\\ 0\\.0017728519790301068\ \(0\)\
\-\ diagnosis\\:\\ 0\\.001766174015103888\ \(0\)\
\-\ lower\\:\\ 0\\.0017298488473122076\ \(0\)\
\-\ contrast\\:\\ 0\\.0017216702851556302\ \(0\)\
\-\ may\\:\\ 0\\.0016870642384321545\ \(0\)\
\-\ with\\:\\ 0\\.001685028638558268\ \(0\)\
\-\ case\\:\\ 0\\.0016827222618067243\ \(0\)\
\-\ large\\:\\ 0\\.0016818563742854002\ \(0\)\
\-\ 2\\:\\ 0\\.001656259672826774\ \(0\)\
\-\ findings\\:\\ 0\\.0016371169539063542\ \(0\)\
\-\ multiple\\:\\ 0\\.0016199874018715291\ \(0\)\
\-\ female\\:\\ 0\\.0015812423685399042\ \(0\)\
\-\ lesion\\:\\ 0\\.001566656369037313\ \(0\)\
\-\ treatment\\:\\ 0\\.0015568109447352718\ \(0\)\
\-\ \\.\\:\\ 0\\.0015337333327386329\ \(0\)\
\-\ seen\\:\\ 0\\.0015199168452454457\ \(0\)\
\-\ is\\:\\ 0\\.0015183369353322924\ \(0\)\
\-\ images\\:\\ 0\\.0014754850512595445\ \(0\)\
\-\ has\\:\\ 0\\.0014443744108859386\ \(0\)\
\-\ disease\\:\\ 0\\.0012571895060447382\ \(0\)\
\-\ are\\:\\ 0\\.0010484913344100824\ \(0\)\
\-\ on\\:\\ 0\\.0006515670678356688\ \(0\)\
